Bone Biologics Corp. EPS (Basic, Consolidated)

EPS (Basic, Consolidated) of BBLG for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS (Basic, Consolidated) growth rates and interactive chart.


Highlights and Quick Summary

  • EPS (Basic, Consolidated) for the quarter ending September 30, 2022 was -0.12 (a 160.04% increase compared to previous quarter)
  • Year-over-year quarterly EPS (Basic, Consolidated) decreased by -100.08%
  • Annual EPS (Basic, Consolidated) for 2021 was -0.35 (a -43.43% decrease from previous year)
  • Annual EPS (Basic, Consolidated) for 2020 was -0.63 (a 33.45% increase from previous year)
  • Twelve month EPS (Basic, Consolidated) ending September 30, 2022 was 148.08 (a 0.04% increase compared to previous quarter)
  • Twelve month trailing EPS (Basic, Consolidated) increased by 0.18% year-over-year
Trailing EPS (Basic, Consolidated) for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
148.08 148.02 147.89 147.81
Visit stockrow.com/BBLG for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS (Basic, Consolidated) of Bone Biologics Corp.

Most recent EPS (Basic, Consolidated)of BBLG including historical data for past 10 years.

Interactive Chart of EPS (Basic, Consolidated) of Bone Biologics Corp.

Bone Biologics Corp. EPS (Basic, Consolidated) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -0.12 -0.05 -0.07
2021 148.3 -0.18 -0.17 -0.15 -0.35
2020 -0.63
2019 -0.47

Business Profile of Bone Biologics Corp.

Sector: Healthcare
Industry: Medical Devices